We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sanifit Raises €36.6M in Series C Financing Round

News   Sep 08, 2015

 
Sanifit Raises €36.6M in Series C Financing Round
 
 
 

RELATED ARTICLES

Salty Skin Could Shape Allergy Progression

News

A new cell culture study reveals that salt leads to the formation of Th2 cells - immune cells which are active in allergic conditions such as atopic dermatitis. The team also detected elevated salt concentrations in the skin of patients with atopic dermatitis.

READ MORE

Therapeutic Approach to Tackle African Sleeping Sickness

News

Scientists working in a range of disciplines joined forces to identify a new approach to combat African sleeping sickness. Their research revealed a promising strategy to develop a suitable agent. This novel concept could also be employed in the future rational design of drugs for the treatment of other diseases.

READ MORE

A Way to Improve Cancer Immunotherapy?

News

A new study has identified a drug that potentially could make a common type of immunotherapy for cancer even more effective. The study in laboratory mice found that the drug dasatinib, which is FDA-approved to treat certain types of leukemia, greatly enhances responses to a form of immunotherapy that is used against a wide range of other cancers.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE